What is the appropriate nitrofurantoin dosing regimen for a 36‑kg pediatric patient at 7 mg/kg/day divided every 6 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nitrofurantoin Dosing Calculation for 36 kg Pediatric Patient

For a 36 kg pediatric patient receiving nitrofurantoin at 7 mg/kg/day divided every 6 hours, administer 63 mg per dose (252 mg total daily dose). This translates to approximately 60-65 mg every 6 hours in clinical practice, depending on available formulation strengths.

Dosing Calculation

Total daily dose:

  • 7 mg/kg/day × 36 kg = 252 mg/day

Individual dose (q6h = 4 doses per day):

  • 252 mg ÷ 4 doses = 63 mg per dose

Dosing schedule:

  • 63 mg PO every 6 hours (at 0600,1200,1800,2400)

Clinical Context and Guideline Support

The 7 mg/kg/day dosing regimen you're using falls within the guideline-recommended range. The 2022 multidrug-resistant organisms guideline specifies nitrofurantoin dosing for pediatrics as 5-7 mg/kg/day PO in 4 divided doses, with a maximum of 100 mg/dose 1. Your prescribed dose of 7 mg/kg/day represents the upper end of this range, which is appropriate for treatment of uncomplicated urinary tract infections.

For this 36 kg patient:

  • The calculated 63 mg per dose is well below the 100 mg maximum per dose
  • The total daily dose of 252 mg is appropriate for this weight

Important Prescribing Considerations

Indication-specific guidance:

  • This dosing is appropriate for uncomplicated cystitis only 1
  • Do not use nitrofurantoin for pyelonephritis or perinephric abscess - the oral formulation does not achieve adequate tissue concentrations outside the urinary tract 1, 2
  • Nitrofurantoin should not be used for febrile UTIs or systemic infections as it does not achieve therapeutic bloodstream concentrations 2

Duration of therapy:

  • Recommended treatment duration is 7 days or at least 3 days after obtaining sterile urine 1
  • For uncomplicated cystitis in adults, 5-day courses are effective 3, though pediatric data support 7-10 day courses 4, 5

Critical Safety Warnings

Contraindications to verify before prescribing:

  • Renal function: Contraindicated if creatinine clearance <60 mL/min or clinically significant elevated serum creatinine 6
  • Age restrictions: Not approved for children <12 years by Taiwan FDA, though widely used off-label with specialist guidance 1
  • G6PD deficiency: Screen for glucose-6-phosphate dehydrogenase deficiency, particularly in patients of African, Mediterranean, or Asian descent, as nitrofurantoin can cause hemolytic anemia 6, 7
  • Pregnancy: Contraindicated at term and in neonates 6

Monitor for adverse effects:

  • Pulmonary reactions (chronic, subacute, or acute) - particularly concerning with prolonged use >6 months 6
  • Peripheral neuropathy - risk increased with renal impairment, anemia, diabetes, electrolyte imbalance, or vitamin B deficiency 6
  • Hepatic reactions including hepatitis and hepatic necrosis 6

Practical Formulation Considerations

Available formulations typically include:

  • 25 mg capsules/tablets
  • 50 mg capsules/tablets
  • 100 mg capsules/tablets

For 63 mg dosing, practical options:

  • Use 50 mg + 25 mg formulations = 75 mg (slightly higher but acceptable)
  • Use 50 mg formulation alone = 50 mg (5.6 mg/kg/day, still within guideline range)
  • If only 100 mg available, consider reducing total daily dose to 5-6 mg/kg/day to avoid exceeding 100 mg per dose

The slight adjustment to accommodate available formulations is clinically acceptable as the guideline range is 5-7 mg/kg/day 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.